908 Devices Newsroom

Correction to 908 Devices Rating

Dow JonesNov 13 13:24 ET

908 Devices Is Maintained at Buy by Stifel

Dow JonesNov 13 10:24 ET

TD Cowen Maintains 908 Devices(MASS.US) With Buy Rating

Moomoo NewsNov 13 08:34 ET

Stifel Maintains 908 Devices(MASS.US) With Buy Rating, Cuts Target Price to $6

Moomoo NewsNov 13 08:33 ET

908 Devices Price Target Announced at $4.00/Share by Leerink Partners

Dow JonesNov 13 07:52 ET

908 Devices Analyst Ratings

BenzingaNov 13 07:42 ET

Leerink Partners Downgrades 908 Devices(MASS.US) to Hold Rating, Cuts Target Price to $4

Moomoo NewsNov 13 06:32 ET

908 Devices Downgraded to Market Perform From Outperform at Leerink

TipRanksNov 13 06:19 ET

TD Cowen Initiates 908 Devices(MASS.US) With Buy Rating

Moomoo NewsNov 12 16:32 ET

TD Cowen Reaffirms Their Buy Rating on 908 Devices (MASS)

TipRanksNov 12 16:31 ET

908 Devices Is Maintained at Outperform by Leerink Partners

Dow JonesOct 17 11:00 ET

908 Devices Analyst Ratings

BenzingaOct 17 10:51 ET

Leerink Partners Maintains 908 Devices(MASS.US) With Buy Rating, Cuts Target Price to $12

Moomoo NewsOct 17 08:31 ET

Buy Rating Affirmed for 908 Devices on Strong Market Position and Growth Prospects

TipRanksAug 9 05:58 ET

TD Cowen Maintains 908 Devices(MASS.US) With Buy Rating

Moomoo NewsAug 6 12:31 ET

908 Devices Analyst Ratings

BenzingaMay 13 10:34 ET

Analysts Offer Insights on Healthcare Companies: BridgeBio Pharma (BBIO), Aurinia Pharmaceuticals (AUPH) and 908 Devices (MASS)

TipRanksMay 2 02:30 ET

Stifel Nicolaus Remains a Buy on 908 Devices (MASS)

TipRanksMar 6 07:40 ET

Stephens & Co. Reiterates Overweight on 908 Devices, Maintains $14 Price Target

BenzingaSep 25, 2023 09:50 ET

908 Devices Analyst Ratings

BenzingaSep 25, 2023 09:49 ET